<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo2403" xml:lang="en" article-type="case-study"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39045030</article-id><article-id pub-id-type="pmc">PMC11263129</article-id>
<article-id pub-id-type="doi">10.1002/deo2.403</article-id><article-id pub-id-type="publisher-id">DEO2403</article-id><article-categories><subj-group subj-group-type="overline"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Steroid lifting method during endoscopic submucosal dissection: A novel strategy for stricture prevention</article-title><alt-title alt-title-type="left-running-head">OMAE <sc>et al</sc>.</alt-title></title-group><contrib-group><contrib id="deo2403-cr-0001" contrib-type="author"><name><surname>Omae</surname><given-names>Masami</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0115-2511</contrib-id><xref rid="deo2403-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2403-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2403-cr-0002" contrib-type="author"><name><surname>Maltzman</surname><given-names>Henrik</given-names></name><xref rid="deo2403-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2403-cr-0003" contrib-type="author"><name><surname>Vujasinovic</surname><given-names>Miroslav</given-names></name><xref rid="deo2403-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2403-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2403-cr-0004" contrib-type="author"><name><surname>Wang</surname><given-names>Naining</given-names></name><xref rid="deo2403-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo2403-cr-0005" contrib-type="author" corresp="yes"><name><surname>Baldaque&#x02010;Silva</surname><given-names>Francisco</given-names></name><xref rid="deo2403-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2403-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="deo2403-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><address><email>baldaque.silva@ki.se</email><email>fbaldaquesilva@gmail.com</email></address></contrib></contrib-group><aff id="deo2403-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Upper Abdominal Diseases</named-content>
<institution>Karolinska University Hospital</institution>
<city>Stockholm</city>
<country country="SE">Sweden</country>
</aff><aff id="deo2403-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Medicine Huddinge</named-content>
<institution>Karolinska Institutet</institution>
<city>Stockholm</city>
<country country="SE">Sweden</country>
</aff><aff id="deo2403-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Pathology</named-content>
<institution>Karolinska University Hospital</institution>
<city>Stockholm</city>
<country country="SE">Sweden</country>
</aff><aff id="deo2403-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<institution>Advanced Endoscopy Center Carlos Moreira da Silva</institution>
<institution>Pedro Hispano Hospital</institution>
<city>Matosinhos</city>
<country country="PT">Portugal</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Francisco Baldaque&#x02010;Silva, Department of Upper Abdominal Diseases, Karolinska University Hospital and Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden, H&#x000e4;lsov&#x000e4;gen 13, 141 86, Stockholm, Sweden.<break/> Email: <email>baldaque.silva@ki.se</email>, <email>fbaldaquesilva@gmail.com</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="104">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e403</elocation-id><history>
<date date-type="rev-recd"><day>11</day><month>6</month><year>2024</year></date>
<date date-type="received"><day>08</day><month>5</month><year>2024</year></date>
<date date-type="accepted"><day>21</day><month>6</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e403.pdf"/><abstract><title>Abstract</title><p>A 73&#x02010;year&#x02010;old male patient was referred to us with a long Barrett's esophagus (BE). He had a history of pulmonary embolism under anticoagulant therapy. Esophagogastroduodenoscopy showed a C8M9 BE with no macroscopic lesions. Random biopsies from the BE revealed multifocal high&#x02010;grade dysplasia. The case was discussed in a multidisciplinary team conference and the decision for full resection of BE with endoscopic submucosal dissection (ESD) was made. Considering the large ESD resection and the high risk of stricture, we developed a novel preventive technique: the &#x0201c;steroid lifting method&#x0201d; for submucosal injection during ESD. Complete circumferential ESD with en bloc resection was performed using the &#x0201c;steroid lifting method&#x0201d;, without adverse events. Oral liquids were initiated on day 1 and the patient was discharged on day 4. Oral prednisolone (30 mg per day) was started and tapered for a total of 6 weeks. The pathological examination confirmed multifocal high&#x02010;grade dysplasia, with radical and curative resection. The patient had neither stricture, dysphagia nor recurrence of Barrett's mucosa at the 2, 6, 12, and 24&#x02010;month follow&#x02010;up. International guidelines recommend oral prednisolone and triamcinolone injection to prevent stricture formation in large ESD of esophageal squamous cell carcinoma. However, there is no solid data on BE ESD. The risk factors for stricture formation and the optimal preventive management after large BE ESD is not known. The &#x0201c;steroid lifting method&#x0201d; might be an option in this context. Large prospective studies addressing stricture formation and preventive measures on BE ESD are necessary.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo2403-kwd-0001">Barrett's esophageal neoplasia</kwd><kwd id="deo2403-kwd-0002">complete circumferential resection</kwd><kwd id="deo2403-kwd-0003">endoscopic submucosal dissection</kwd><kwd id="deo2403-kwd-0004">esophageal stricture</kwd><kwd id="deo2403-kwd-0005">steroid lifting method</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="4"/><table-count count="0"/><page-count count="5"/><word-count count="2266"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo2403-sec-0010"><title>INTRODUCTION</title><p>Endoscopic submucosal dissection (ESD) was developed for en&#x02010;bloc resection of early gastrointestinal neoplasms. The role of ESD is established in superficial esophageal squamous cell neoplasia, early gastric neoplasia, and some colorectal lesions according to several international guidelines.<xref rid="deo2403-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="deo2403-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> However, ESD is not yet the standard treatment for Barrett's esophageal neoplasia (BEN). Current guidelines recommend endoscopic resection of visible neoplastic lesions in Barrett's mucosa. Ablation of the remaining Barrett's esophagus (BE) is recommended due to the risk of synchronous or metachronous neoplasia in 11&#x02013;47% of patients.<xref rid="deo2403-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="deo2403-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo2403-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> In most Western centers, endoscopic resection of BEN is performed with endoscopic mucosal resection due to its safety profile and feasibility in an outpatient setting. Patients with focal dysplastic lesions in long segment BE need several sessions of both endoscopic resection and ablative treatments. These treatments &#x02013; endoscopic mucosal resection, ESD, and radiofrequency ablation &#x02013; may be associated with stricture formation, which affects patients&#x02019; quality of life and increases the costs of BE treatment. We developed a novel strategy for stricture prevention, the &#x0201c;steroid lifting method&#x0201d; that aims to reduce stricture formation in large BE ESDs. We present a case of complete circumferential resection of multifocal high&#x02010;grade dysplasia (HGD) using this novel technique to prevent stricture formation during the 24&#x02010;month follow&#x02010;up period.</p></sec><sec id="deo2403-sec-0020"><title>CASE REPORT</title><p>A 73&#x02010;year&#x02010;old male&#x000a0;patient with a history of pulmonary embolism under anticoagulant therapy was referred to us due to an long segment BE&#x000a0;(C8M9) with positive biopsies for HGD. A new esophagogastroduodenoscopy (EGD) was performed at our center using white light, narrow band imaging, and chromoscopy with acetic acid. No macroscopic lesions were detected (Figure&#x000a0;<xref rid="deo2403-fig-0001" ref-type="fig">1</xref>). However, random biopsies confirmed the presence of multifocal HGD along the BE.</p><fig position="float" fig-type="FIGURE" id="deo2403-fig-0001"><label>FIGURE 1</label><caption><p>Endoscopic evaluation before endoscopic submucosal dissection. (a) White&#x02010;light imaging showing Barrett's esophagus (C8M9) without any visible lesions. (b) Narrow band imaging shows no visible lesions in Barrett's esophagus. (c) White&#x02010;light imaging with the application of acetic acid showing no visible lesions. d. Narrow band imaging with applications of acetic acid showing no visible lesions.</p></caption><graphic xlink:href="DEO2-5-e403-g001" position="anchor" id="jats-graphic-1"/></fig><p>This case was discussed at a multidisciplinary team conference and the decision for full resection of BE with ESD was made. The procedure was planned after the patient's signed informed consent.</p><sec id="deo2403-sec-0030"><title>The steroid lifting method</title><p>Succinylated gelatin (Gelofusine; B. Braun Medical AB) is a colloidal plasma volume substitute commonly used in fluid resuscitation. Compared to hyaluronic acid, it is cheaper, more available in the West, and easier to mix with solutions like indigo carmine, adrenaline, and steroids. It can also be used through ESD needles in the &#x0201c;water jet.&#x0201d; In this method, 500 mL of succinylated gelatin&#x000a0;is mixed with 3 mL of indigo carmine and used for submucosal injection. One milliliter of triamcinolone acetonide (Kenakort; Bristol&#x02010;Myers Squibb, 40 mg/mL) is mixed with 3 mL saline solutions in a 5 mL syringe (referred to as syringe A). Nine milliliters of Gelofusine are then mixed with 1 mL of the mixture from syringe A, in a 10 mL syringe (syringe B). This mixture is used as the lifting solution during the ESD procedure (Figure&#x000a0;<xref rid="deo2403-fig-0002" ref-type="fig">2</xref>).</p><fig position="float" fig-type="FIGURE" id="deo2403-fig-0002"><label>FIGURE 2</label><caption><p>Material needed for the steroid lifting methods. (a) 1 mL syringe. (b) 18&#x02010;gauge needle. (c) 5 mL syringe. (d) 10 mL syringe. (e) Gelofusine. (f) Saline solution. (g) Indigo carmine. (h) Triamcinolone acetonide. One milliliter of triamcinolone acetonide 40 mg/mL (h) is aspirated with an 18&#x02010;gauge needle (b) using a 1 mL syringe (a) and then mixed with 3 mL of saline solution (f) in a 5 mL syringe (c). (referred to as syringe A). Nine milliliters of Gelofusine (e) are then mixed with 1 mL of the mixture from syringe A in a 10 mL syringe (referred to as syringe B). (d) This mixture is used as the lifting solution during the endoscopic submucosal dissection procedure.</p></caption><graphic xlink:href="DEO2-5-e403-g004" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="deo2403-sec-0040"><title>Endoscopic submucosal dissection</title><p>Before ESD, marking dots were placed in the proximal and distal BE margins using the dual knife (KD&#x02010;650 L; Olympus). The steroid lifting solution was then used for submucosal lifting and mucosal incision was performed on the distal and proximal side margins. The same solution was used during the ESD when needed for additional submucosal lifting. Two tunnels were created during ESD using the clip&#x02010;and&#x02010;thread technique.<xref rid="deo2403-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> Complete en&#x02010;bloc resection was obtained without complications (Figure&#x000a0;<xref rid="deo2403-fig-0003" ref-type="fig">3</xref>). A total of 200 mg triamcinolone acetonide was used in the lifting solution during the ESD. The retrieved specimen was 108 &#x000d7; 45 mm in size. The liquid diet was resumed on day 1 and the patient was discharged from the hospital on day 4. Oral prednisolone was given for 6 weeks, starting at the dose of 30 mg per day. The pathological examination confirmed multifocal HGD with radical (R0) and curative resection. Follow&#x02010;up EGD showed no sign of stricture and no recurrence of the BE at 2, 6, 12, and 24 months. (Figure&#x000a0;<xref rid="deo2403-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="FIGURE" id="deo2403-fig-0003"><label>FIGURE 3</label><caption><p>The endoscopic submucosal dissection procedure. (a) The proximal side of the lesion with markings. (b) A clip&#x02010;and&#x02010;thread technique was used. Black arrow shows a whitish area corresponding to triamcinolone in the submucosal layer. (c) The mucosal defect after endoscopic mucosal dissection. Black arrow shows a whitish area corresponding to triamcinolone in the submucosal layer. (d) The resected specimen was 108 &#x000d7; 45 mm.</p></caption><graphic xlink:href="DEO2-5-e403-g003" position="anchor" id="jats-graphic-5"/></fig><fig position="float" fig-type="FIGURE" id="deo2403-fig-0004"><label>FIGURE 4</label><caption><p>Follow&#x02010;up endoscopy at 2 and 6 months follow up. (a, b) WLI showing fibrin&#x02010;coated ulcer without any signs of stricture and recurrence of Barrett's esophagus at 2 months. (c, d) White&#x02010;light imaging showing an endoscopic submucosal dissection scar without any signs of stricture or recurrence of the Barrett's esophagus at 6 months follow&#x02010;up.</p></caption><graphic xlink:href="DEO2-5-e403-g002" position="anchor" id="jats-graphic-7"/></fig></sec></sec><sec id="deo2403-sec-0050"><title>DISCUSSION</title><p>Endoscopic submucosal dissection enables en&#x02010;bloc resection of neoplastic lesions and has been widely used along the gastrointestinal tract except for BEN. Initial reports of ESD for BEN were discouraging due to the high rate of positive lateral margins and a significant rate of complications. More recent studies have shown good efficacy of ESD for BEN, with lateral R0 rates of 75%&#x02013;90%.<xref rid="deo2403-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> In our early series of neoplastic BE treated with ESD, the rates of en bloc, R0 and curative resection were 99%, 86%, and 72%, respectively.<xref rid="deo2403-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> However, ESD of BEN may be associated with adverse events such as stricture formation in the esophagus during the healing process. This complication is now the primary factor preventing the widespread use of ESD for BEN. The risk of stricture is high in previous studies, with larger specimens and a greater percentage of resected lumen circumference further increasing this risk.<xref rid="deo2403-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>
</p><p>With the available options, stricture formation after esophageal ESD represents a big burden for the patients, medical staff, and health services. The most commonly used strategies to prevent esophageal strictures are corticosteroid therapy, particularly oral prednisolone, and local triamcinolone injection. However, there are some risks associated with systemic steroid use. These risks include hyperglycemia, cytomegalovirus enterocolitis and other infections, cardiac arrhythmia, hypokalemia, and psychological disorders. Triamcinolone injection also carries a risk of perforation, necrosis, and bleeding, with severe outcomes in some cases. Additionally, triamcinolone injection is traditionally performed after ESD and is time&#x02010;consuming. Furthermore, neither oral prednisolone nor local triamcinolone injection has been shown to be effective in circumferential ESD.<xref rid="deo2403-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>
</p><p>Other preventive strategies have been described in small series, such as endoscopic metal stents, injection of botulinum toxin type A, oral administration of tranilast (N&#x02010;[3,4&#x02010;dimethoxycinnamoyl]&#x02010;anthranilic acid), tissue&#x02010;shielding methods with polyglycolic acid and oral budesonide.<xref rid="deo2403-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> It is not known how these preventive strategies impact results as BEN ESD is not widely performed in the West, resulting in a lack of data.</p><p>There are some advantages of our novel prevention technique. The steroid lifting method is performed directly during ESD and uses conventional devices. It has a topical effect, and no additional procedure time is required afterward. The treatment is also fast to deliver, has low costs, and may be associated with a lower risk of perforation compared to the current triamcinolone injection method because the submucosal layer can be identified during ESD. We argue that this method may be more effective for superficial ESD layers, as triamcinolone can be retained in the ulcer, but less effective for deeper layers often involved in malignant lesions. However, this method ensures that the steroid spreads across different layers of the submucosa, allowing it to reach free submucosal tissue regardless of tumor depth. Injecting steroids before the incision means they will be present not only in the ulcer after ESD but also in the surrounding healthy tissue. A whitish area can also be detected during ESD (Figure&#x000a0;<xref rid="deo2403-fig-0003" ref-type="fig">3b,c</xref>, black arrows) as a result of the steroid injection.<xref rid="deo2403-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> However, due to a lack of data, it is unclear if this method is superior to the current steroid injection technique. Additionally, in this case, the impact of the steroid lifting method on stricture prevention remains uncertain as the patient also took systemic steroids. There is a need to further evaluate the risk factors for stricture formation and identify the best strategies for its prevention.</p><p>Herein, we present a new technique for the prevention of strictures that is easy to deliver, cheap, and safe. The procedure was performed without complications in our patient, who had a 9 cm long segment BE and the width of the resected specimens of BE was 45 mm. However, prospective studies are needed to test and validate this novel strategy.</p></sec><sec sec-type="COI-statement" id="deo2403-sec-0060"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo2403-sec-0070"><title>ETHICS STATEMENT</title><p>Not applicable.</p></sec><sec id="deo2403-sec-0080"><title>PATIENT INFORMED CONSENT</title><p>Complete written informed consent was obtained from the patient for the publication of this study and accompanying images.</p></sec></body><back><ref-list id="deo2403-bibl-0001"><title>REFERENCES</title><ref id="deo2403-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo2403-cit-0001">
<string-name>
<surname>Pimentel&#x02010;Nunes</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Libanio</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bastiaansen</surname>
<given-names>BAJ</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline &#x02013; Update 2022</article-title>. <source>Endoscopy</source>
<year>2022</year>; <volume>54</volume>: <fpage>591</fpage>&#x02013;<lpage>622</lpage>.<pub-id pub-id-type="pmid">35523224</pub-id>
</mixed-citation></ref><ref id="deo2403-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo2403-cit-0002">
<string-name>
<surname>Forbes</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Elhanafi</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Haddad</surname>
<given-names>MA</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: Summary and recommendations</article-title>. <source>Gastrointest Endosc</source>
<year>2023</year>; <volume>98</volume>: <fpage>271</fpage>&#x02013;<lpage>284</lpage>.<pub-id pub-id-type="pmid">37498266</pub-id>
</mixed-citation></ref><ref id="deo2403-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo2403-cit-0003">
<string-name>
<surname>Koike</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nakagawa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Iijima</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic resection (endoscopic submucosal dissection/endoscopic mucosal resection) for superficial Barrett's esophageal cancer</article-title>. <source>Dig Endosc</source>
<year>2013</year>; <volume>25</volume> (Suppl <issue>1</issue>): <fpage>20</fpage>&#x02013;<lpage>28</lpage>.</mixed-citation></ref><ref id="deo2403-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo2403-cit-0004">
<string-name>
<surname>Yamasaki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Takeuchi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hanaoka</surname>
<given-names>N</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A novel traction method using an endoclip attached to a nylon string during colonic endoscopic submucosal dissection</article-title>. <source>Endoscopy</source>
<year>2015</year>; <volume>47</volume> (Suppl <issue>1</issue> UCTN): <fpage>E238</fpage>&#x02013;<lpage>239</lpage>.<pub-id pub-id-type="pmid">26069981</pub-id>
</mixed-citation></ref><ref id="deo2403-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo2403-cit-0005">
<string-name>
<surname>Subramaniam</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chedgy</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Longcroft&#x02010;Wheaton</surname>
<given-names>G</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Complex early Barrett's neoplasia at 3 Western centers: European Barrett's Endoscopic Submucosal Dissection Trial (E&#x02010;BEST)</article-title>. <source>Gastrointest Endosc</source>
<year>2017</year>; <volume>86</volume>: <fpage>608</fpage>&#x02013;<lpage>618</lpage>.<pub-id pub-id-type="pmid">28159540</pub-id>
</mixed-citation></ref><ref id="deo2403-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo2403-cit-0006">
<string-name>
<surname>Omae</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hagstrom</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ndegwa</surname>
<given-names>N</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Wide&#x02010;field endoscopic submucosal dissection for the treatment of Barrett's esophagus neoplasia</article-title>. <source>Endosc Int Open</source>
<year>2021</year>; <volume>9</volume>: <fpage>E727</fpage>&#x02013;<lpage>E734</lpage>.<pub-id pub-id-type="pmid">33937514</pub-id>
</mixed-citation></ref><ref id="deo2403-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo2403-cit-0007">
<string-name>
<surname>Chen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>C</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Lesion size and circumferential range identified as independent risk factors for esophageal stricture after endoscopic submucosal dissection</article-title>. <source>Surg Endosc</source>
<year>2020</year>; <volume>34</volume>: <fpage>4065</fpage>&#x02013;<lpage>4071</lpage>.<pub-id pub-id-type="pmid">31953729</pub-id>
</mixed-citation></ref><ref id="deo2403-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo2403-cit-0008">
<string-name>
<surname>Kadota</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Prophylactic steroid administration for strictures after endoscopic resection of large superficial esophageal squamous cell carcinoma</article-title>. <source>Endosc Int Open</source>
<year>2016</year>; <volume>4</volume>: <fpage>E1267</fpage>&#x02013;<lpage>E1274</lpage>.<pub-id pub-id-type="pmid">28028531</pub-id>
</mixed-citation></ref><ref id="deo2403-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo2403-cit-0009">
<string-name>
<surname>Bartel</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Mousa</surname>
<given-names>OY</given-names>
</string-name>, <string-name>
<surname>Brahmbhatt</surname>
<given-names>B</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Impact of topical budesonide on prevention of esophageal stricture after mucosal resection</article-title>. <source>Gastrointest Endosc</source>
<year>2021</year>; <volume>93</volume>: <fpage>1276</fpage>&#x02013;<lpage>1282</lpage>.<pub-id pub-id-type="pmid">33309653</pub-id>
</mixed-citation></ref><ref id="deo2403-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo2403-cit-0010">
<string-name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Arimura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Okahara</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection</article-title>. <source>BMC Gastroenterol</source>
<year>2015</year>; <volume>15</volume>: <fpage>1</fpage>.<pub-id pub-id-type="pmid">25609176</pub-id>
</mixed-citation></ref></ref-list></back></article>